Td Private Client Wealth LLC Moderna, Inc. Transaction History

Td Private Client Wealth LLC

  • $4.44 Trillion
  • Q3 2025

A detailed history of Td Private Client Wealth LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 1,293 shares of MRNA stock, worth $35,117. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,293
Previous 956 35.25%
Holding current value
$35,117
Previous $26.4 Million 26.62%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 27, 2025
BUY
$23.51 - $34.67 $7,922 - $11,683
337 Added 35.25%
1,293 $33.4 Million
Q2 2025

Jul 15, 2025
BUY
$23.65 - $28.54 $17,571 - $21,205
743 Added 348.83%
956 $26.4 Million
Q1 2025

Apr 29, 2025
BUY
$28.35 - $47.53 $4,989 - $8,365
176 Added 475.68%
213 $6.04 Million
Q4 2024

Feb 11, 2025
SELL
$36.85 - $63.93 $11,128 - $19,306
-302 Reduced 89.09%
37 $1.54 Million
Q3 2024

Nov 18, 2024
SELL
$63.64 - $125.14 $14,000 - $27,530
-220 Reduced 39.36%
339 $22.7 Million
Q2 2024

Aug 14, 2024
BUY
$101.21 - $166.61 $56,576 - $93,134
559 New
559 $66.4 Million
Q1 2024

Aug 16, 2024
SELL
$85.37 - $115.44 $18,610 - $25,165
-218 Reduced 33.75%
428 $45.6 Million
Q4 2023

Aug 16, 2024
SELL
$69.51 - $104.43 $20,366 - $30,597
-293 Reduced 31.2%
646 $64.2 Million
Q3 2023

Aug 16, 2024
SELL
$96.41 - $126.61 $487,931 - $640,773
-5,061 Reduced 84.35%
939 $97 Million
Q2 2023

Aug 16, 2024
SELL
$118.5 - $160.53 $26,070 - $35,316
-220 Reduced 3.54%
6,000 $729 Million
Q1 2023

Aug 16, 2024
SELL
$135.66 - $197.02 $333,994 - $485,063
-2,462 Reduced 28.36%
6,220 $955 Million
Q4 2022

Aug 16, 2024
SELL
$118.38 - $210.04 $234,274 - $415,669
-1,979 Reduced 18.56%
8,682 $1.56 Billion
Q3 2022

Aug 16, 2024
SELL
$118.07 - $194.18 $22,197 - $36,505
-188 Reduced 1.73%
10,661 $1.26 Billion
Q2 2022

Aug 16, 2024
BUY
$117.13 - $176.59 $1.22 Million - $1.84 Million
10,400 Added 2316.26%
10,849 $1.55 Billion
Q1 2022

Aug 16, 2024
BUY
$126.46 - $235.05 $52,101 - $96,840
412 Added 1113.51%
449 $77.3 Million
Q4 2021

Aug 16, 2024
SELL
$225.82 - $368.51 $72,714 - $118,660
-322 Reduced 89.69%
37 $9.4 Million
Q3 2021

Aug 16, 2024
SELL
$221.9 - $484.47 $44,380 - $96,894
-200 Reduced 35.78%
359 $138 Million
Q1 2021

Aug 16, 2024
SELL
$109.18 - $185.98 $31,553 - $53,748
-289 Reduced 90.88%
29 $3.8 Million
Q3 2020

Aug 16, 2024
BUY
$54.34 - $94.85 $9,509 - $16,598
175 Added 122.38%
318 $22.5 Million
Q2 2020

Aug 16, 2024
BUY
$29.67 - $80.0 $207 - $560
7 Added 5.15%
143 $9.18 Million
Q1 2020

Aug 16, 2024
BUY
$17.78 - $31.58 $1,280 - $2,273
72 Added 112.5%
136 $4.07 Million
Q4 2019

Aug 16, 2024
SELL
$13.93 - $21.28 $6,895 - $10,533
-495 Reduced 88.55%
64 $1.25 Million

Others Institutions Holding MRNA

# of Institutions
857
Shares Held
266M
Call Options Held
28.5M
Put Options Held
34.9M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $10.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email